There is an emerging body of evidence on simplified models for chronic disease care disruption due to acute conflict, disasters, and now, a pandemic.11,12 In 2019, IRC clinics had prioritized a cohort of Syrian and vulnerable Jordanian hypertension and diabetes patients at high risk of developing severe disease and reliant on free medications/insulin. This evidence concerns the gene INS and diabetes mellitus.